Timing Is Everything: Optimizing Diagnosis and Personalized Treatment With First-Line Immunotherapy Plus Chemotherapy in Advanced Biliary Tract Cancer

Nov 15 2024
Convention Center: Ballroom 20 D
12:30 PM - 2:00 PM

World Class Speakers

AH
Industry Presenter

Aiwu Ruth He, MD

Georgetown University Hospital
Lewis R Roberts, MBChB, PhD, FAASLD
Industry Presenter

Lewis R Roberts, MBChB, PhD, FAASLD

Mayo Clinic Rochester

Description

Two leading experts in biliary tract cancer—an oncologist and a hepatologist—will share best practices for early diagnosis and first-line treatment of advanced BTC with immunotherapy plus chemotherapy combinations, including multidisciplinary strategies to enhance patient quality of life on treatment and off. 

Supported by:  This activity is supported by an educational grant from AstraZeneca. 

Organizer: Answers in CME

For more information and to register, visit: https://d.answersincme.com/160203412_1/160203412_1_p1/stage1reg?CountryID=US&interactionId=Bo7aubF_BYMKCF4akKG4PbUG20MkmiiISDwhHP1bavPZG2QJOSRb3w%3D%3D&ProjectNumber=160203412_1

Objectives

  • Identify best practices for early recognition of patients with biliary tract cancer (BTC) to optimize diagnosis
  • Discuss multidisciplinary strategies to address key diagnostic challenges in advanced BTC
  • Describe the clinical profiles of immune checkpoint inhibitor (ICI) plus chemotherapy combinations for the first-line treatment for advanced BTC
  • Outline multidisciplinary approaches to enhance care of patients with advanced BTC on an ICI plus chemotherapy combination